Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Pluristem Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Apr 2016 Reuters Investment Profile 12 $20.00

Pluristem Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Apr 2016 Reuters Investment Profile 12 $20.00

ValuEngine Rating and Forecast Report for PSTI

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

01 May 2016 ValuEngine, Inc. 11 $25.00

PLURISTEM THERAPEUTICS INC (PSTI=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

30 Apr 2016 Pechala's Reports 2 $25.00

Thomson Reuters Stock Report - Pluristem Therapeutics Inc (PSTI-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Apr 2016 Thomson Reuters Stock Report 12 $25.00

Wright Investors Service Comprehensive Report for Pluristem Therapeutics Incorporation.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

26 Apr 2016 Wright Reports 56 $75.00

Pluristem Therapeutics Inc. (PSTI) - Financial Analysis Review

Pluristem Therapeutics Inc. (PSTI) - Financial Analysis Review Summary Pluristem Therapeutics Inc. (Pluristem) is a biotechno...

18 Apr 2016 GlobalData 52 $300.00

Pluristem Therapeutics Inc. (PSTI) - Financial Analysis Review

Pluristem Therapeutics Inc. (PSTI) - Financial Analysis Review Summary Pluristem Therapeutics Inc. (Pluristem) is a biotechno...

17 Mar 2016 GlobalData 53 $300.00

Pluristem Therapeutics Inc.: Downgraded to Above Average

20 Jan 2016 Sadif Analytics Prime 3 $10.00

Pluristem Therapeutics Inc. (PSTI) - Financial Analysis Review

Pluristem Therapeutics Inc. (PSTI) - Financial Analysis Review Summary Pluristem Therapeutics Inc. (Pluristem) is a biotechno...

15 Dec 2015 GlobalData 62 $300.00